Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans

Infection and Immunity

Volumn 80, Issue 9, 2012, Pages 3065-3076

  Nicola, André Moraes ^a,b   Albuquerque, Patrícia ^a,c   Martinez, Luis R ^a,d   Dal Rosso, Rafael Antonio ^a   Saylor, Carolyn ^a   De Jesus, Magdia ^a,e   Nosanchuk, Joshua D ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

^c UNIVERSITY OF BRASILIA   (Brazil)

^d LONG ISLAND UNIVERSITY   (United States)

^e WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY PROTEIN 5; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3 ALPHA; OPSONIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANDIDA ALBICANS; CELL SURVIVAL; CELL VACUOLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE RELEASE; EXOCYTOSIS; FEMALE; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; FUNGUS IMMUNITY; GENE SILENCING; HOST PATHOGEN INTERACTION; HUMORAL IMMUNITY; IN VITRO STUDY; INFECTION SENSITIVITY; INFLAMMATION; INVASIVE CANDIDIASIS; MACROAUTOPHAGY; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE AUTOPHAGY; MALE; MOUSE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84867605302     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00358-12     Document Type: Article

References (52)

1. Alonso S, Pethe K, Russell DG, Purdy GE. 2007. Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc. Natl. Acad. Sci. U. S. A. 104:6031-6036.
2. Alvarez M, Casadevall A. 2006. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr. Biol. 16:2161-2165.
3. Casadevall A, et al. 1998. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob. Agents Chemother. 42:1437-1446.
4. Cross CE, Collins HL, Bancroft GJ. 1997. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans. Immunology 91:289-296.
5. Deray G. 2002. Amphotericin B nephrotoxicity. J. Antimicrob. Chemother. 49(Suppl 1):37-41.
6. Deretic V, Levine B. 2009. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 5:527-549.
7. Deselm CJ, et al. 2011. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev. Cell 21:966-974.
8. Dromer F, Casadevall A, Perfect JR, Sorrell T. 2011. Cryptococcus neoformans: latency and disease. In Heitman J, Kozel TR, Kwon-Chung JK, Perfect JR, Casadevall A (ed), Cryptococcus from human pathogen to model yeast. ASM Press, Washington, DC.
9. Eggimann P, Bille J, Marchetti O. 2011. Diagnosis of invasive candidiasis in the ICU. Ann. Intensive Care 1:37.
10. Feldmesser M, Kress Y, Novikoff P, Casadevall A. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68:4225-4237.
11. Goldman DL, et al. 2001. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 107:E66. doi:10.1542/ peds.107.5.e66.
12. Gutierrez MG, et al. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119:753-766.
13. Hara T, et al. 2006. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441:885-889.
14. Harris J. 2011. Autophagy and cytokines. Cytokine 56:140-144.
15. Hoermannsperger G, et al. 2009. Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PLoS One 4:e4365. doi:10.1371/journal.pone.0004365.
16. Hu G, et al. 2008. PI3K signaling of autophagy is required for starvation tolerance and virulence of Cryptococcus neoformans. J. Clin. Invest. 118: 1186-1197.
17. Jackson WT, et al. 2005. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol. 3:e156. doi:10.1371/journal.pbio.0030156.
18. Kabeya Y, et al. 2000. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19: 5720-5728.
19. Kim J, Sudbery P. 2011. Candida albicans, a major human fungal pathogen. J. Microbiol. 49:171-177.
20. Levine B, Mizushima N, Virgin HW. 2011. Autophagy in immunity and inflammation. Nature 469:323-335.
21. Levitz SM, et al. 1999. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67:885-890.
22. Liang XH, et al. 1998. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J. Virol. 72:8586-8596.
23. Liu M, et al. 2011. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 22:121-130.
24. Ma H, Croudace JE, Lammas DA, May RC. 2006. Expulsion of live pathogenic yeast by macrophages. Curr. Biol. 16:2156-2160.
25. Michalec L, et al. 2002. CCL7 and CXCL10 orchestrate oxidative stressinduced neutrophilic lung inflammation. J. Immunol. 168:846-852.
26. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. 2008. Autophagy fights disease through cellular self-digestion. Nature 451:1069-1075.
27. Mizushima N, et al. 2001. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J. Cell Biol. 152:657-668.
28. Nakamura K, et al. 2006. Limited contribution of Toll-like receptor 2 and 4 to the host response to a fungal infectious pathogen, Cryptococcus neoformans. FEMS Immunol. Med. Microbiol. 47:148-154.
29. Nicola AM, Casadevall A. 2012. In vitro measurement of phagocytosis and killing of Cryptococcus neoformans by macrophages. Methods Mol. Biol. 844:189-197.
30. Nicola AM, Frases S, Casadevall A. 2009. Lipophilic dye staining of Cryptococcus neoformans extracellular vesicles and capsule. Eukaryot. Cell 8:1373-1380.
31. Nicola AM, Robertson EJ, Albuquerque P, Derengowski Lda S, Casadevall A. 2011. Nonlytic exocytosis of Cryptococcus neoformans from macrophages occurs in vivo and is influenced by phagosomal pH. mBio 2(4):e00167-11. doi:10.1128/mBio.00167-11.
32. Palmer GE, Kelly MN, Sturtevant JE. 2007. Autophagy in the pathogen Candida albicans. Microbiology 153:51-58.
33. Park BJ, et al. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525-530.
34. Perfect JR, et al. 2010. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 50:291-322.
35. Ponpuak M, et al. 2010. Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity 32:329-341.
36. Pruzanski W, Saito S. 1988. Comparative study of phagocytosis and intracellular bactericidal activity of human monocytes and polymorphonuclear cells. Application of fluorochrome and extracellular quenching technique. Inflammation 12:87-97.
37. Qin QM, et al. 2011. Functional analysis of host factors that mediate the intracellular lifestyle of Cryptococcus neoformans. PLoS Pathog. 7:e1002078. doi:10.1371/journal.ppat.1002078.
38. Raes G, et al. 2002. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukoc. Biol. 71:597-602.
39. Rich KA, Burkett C, Webster P. 2003. Cytoplasmic bacteria can be targets for autophagy. Cell. Microbiol. 5:455-468.
40. Sanjuan MA, et al. 2007. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450:1253-1257.
41. Saylor CA, Dadachova E, Casadevall A. 2010. Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of Cryptococcus neoformans through different receptors. J. Immunol. 184:336-343.
42. Schlegel A, Giddings TH, Jr, Ladinsky MS, Kirkegaard K. 1996. Cellular origin and ultrastructure of membranes induced during poliovirus infection. J. Virol. 70:6576-6588.
43. Siddiqui AA, Shattock RJ, Harrison TS. 2006. Role of capsule and interleukin-6 in long-term immune control of Cryptococcus neoformans infection by specifically activated human peripheral blood mononuclear cells. Infect. Immun. 74:5302-5310.
44. Taborda CP, Casadevall A. 2002. CR3 (CD11b/CD18) and CR4 (CD11c/ CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 16:791-802.
45. Takenouchi T, et al. 2009. The activation of P2X7 receptor impairs lysosomal functions and stimulates the release of autophagolysosomes in microglial cells. J. Immunol. 182:2051-2062.
46. Tollin M, et al. 2003. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 24:523-530.
47. van de Veerdonk FL, Kullberg BJ, Netea MG. 2010. Pathogenesis of invasive candidiasis. Curr. Opin. Crit. Care 16:453-459.
48. Villamon E, et al. 2004. Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect. 6:1-7.
49. Yauch LE, Mansour MK, Shoham S, Rottman JB, Levitz SM. 2004. Involvement of CD14, Toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect. Immun. 72:5373-5382.
50. Zaragoza O, et al. 2009. The capsule of the fungal pathogen Cryptococcus neoformans. Adv. Appl. Microbiol. 68:133-216.
51. Zhao Z, et al. 2008. Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell Host Microbe 4:458-469.
52. Zhao Z, et al. 2007. Coronavirus replication does not require the autophagy gene ATG5. Autophagy 3:581-585.